The notices it replaced
- Reissues: RFA-AI-19-068 Immune Tolerance Network (UM1 Clinical Trial Required)
- 2 steps back: RFA-AI-12-043 Collaborative Network for Clinical Research on Immune Tolerance (UM1)
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $59,882,216 in first-year total cost, median $29,941,108.
Most frequent study sections
- Special Emphasis Panel[ZAI1 PTM-I (S3)]1
- Special Emphasis Panel[ZAI1 TC-I (S3)]1
Most frequent institutions
- BENAROYA RESEARCH INST AT VIRGINIA MASON2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Immune Tolerance Network2UM1AI109565-08 · under RFA-AI-19-068 | NEPOM, GERALD T | BENAROYA RESEARCH INST AT VIRGINIA MASON, WA | $29,550,346 | ZAI1 |
| 2014 | Immune Tolerance Network1UM1AI109565-01 · under RFA-AI-12-043 | NEPOM, GERALD T | BENAROYA RESEARCH INST AT VIRGINIA MASON, WA | $30,331,870 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.